Ann Arbor Company, Millendo Therapeutics, Sets Michigan Record by Raising $62 Million

Millendo Therapeutics, Inc., today announced that it has entered into an exclusive license agreement with AstraZeneca for the worldwide development and commercialization rights to AZD4901, a product candidate for the treatment of polycystic ovary syndrome (PCOS), the most common endocrine disease in women. The Company will develop the compound as MLE4901. In addition, Millendo has secured a $62 million Series B investment led by New Enterprise Associates,... [Read More...]

Nine Companies Receive Michigan Microloan Fund Program Support

Nine Michigan companies have received a combined total of more than $478,000 through the Michigan Microloan Fund Program, bringing the total amount invested through the Fund to more than $2 million.  The companies received the funding to support commercialization of their core products. “Microloan funding, by design, is that bit of extra support that a company needs to bring a product to market,” said Skip Simms, Ann Arbor SPARK senior vice... [Read More...]

Another Job Landed!

We all know how difficult job-searching can be these days. Spending hours combing through jobs posting, meticulously editing your resume, attending seemingly endless rounds of interviews, and dealing with rejections–sound familiar? The good news is that there is a light at the end of the tunnel, because when you find that perfect job all your searching will seem validated. Below is a story submitted to us from Jimmy Hurley, a recent graduate... [Read More...]